Positive Peers Intervention Clinical Trial
Part of paid clinical trials in Van Nuys, California.
- Sponsor
- MetroHealth Medical Center
- Study ID
- NCT06388109
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 34 Years
- Healthy Volunteers
- Not accepted
Interventions
- Positive Peers mobile app — OTHERPositive Peers is a multifunctional mobile app using a mind, body, spirit theme aimed to improve HIV care outcomes.
Study Details
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Key Dates
- Start date
- Jun 3, 2024
- Status verified
- Oct 2025
- Primary completion
- May 31, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Immediate StartParticipants in the immediate start arm will download and begin use of the Positive Peers app at the enrollment visit.
- Active Comparator: Delayed StartParticipants in the delayed start arm will download and begin use of the Positive Peers app 6 months after enrollment
- No Intervention: Observational CohortParticipants in the observational cohort have declined participation in the clinical trial but agree to do the baseline survey and have medical outcomes data recorded.
Primary Outcome Measure
Viral suppression [ Time Frame: 6 months ]
Central Contacts
- Jennifer McMillen-Smith, LISW-S2167784051
- Ann Avery, MD
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northeast Valley Health Corporation | Van Nuys | California | 91405 | Herberth Osorio, MPH (PRINCIPAL_INVESTIGATOR) |
| Infectious Disease Practice- Rutgers University | Newark | New Jersey | 07103 | Sireesha Kada Shoba Swaminathan, MD (PRINCIPAL_INVESTIGATOR) |
| Equitas Health | Cincinnati | Ohio | 45206 | Tania Slack-Peterson Kelly Wesp, PhD (PRINCIPAL_INVESTIGATOR) |
| Equitas Health | Columbus | Ohio | 43203 | Tania Slack-Peterson Kelly Wesp, PhD (PRINCIPAL_INVESTIGATOR) |
| Thomas Street Clinic | Houston | Texas | 77004-8004 | Ernesto Linares Pineda Shital Patel, MD (PRINCIPAL_INVESTIGATOR) |
| UW Madison Clinic at Harborview | Seattle | Washington | 98104 | Amari Perry H Nina Kim, MD, MPH (PRINCIPAL_INVESTIGATOR) Raaka Kumbhakar, MD (SUB_INVESTIGATOR) |
Find similar trials in Van Nuys, CA
By condition
By specialty
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- HIV Prevention Among At-risk Latinos in the HeartlandEnrolling By Invitation · Medical College of Wisconsin · Indianapolis, Indiana
- CAR-T Cells for HIV InfectionPHASE1/PHASE2 · Recruiting · Steven Deeks · Sacramento, California